Search

Author/Creator Nnane, Ivo

1. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Issue 5 (13th January 2017)

Authors:
Smolen, Josef S; Agarwal, Sandeep K; Ilivanova, Elena; Xu, Xie Lillian; Miao, Ye; Zhuang, Yanli; Nnane, Ivo; Radziszewski, Waldemar; Greenspan, Andrew; Beutler, Anna; Baker, Daniel
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 5(2017)
Page Start:
831
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A. Issue 1 (1st January 2020)

Authors:
Zheng, Songmao; Shen, Fang; Jones, Brian; Fink, Damien; Geist, Brian; Nnane, Ivo; Zhou, Zhao; Hall, Jeff; Malaviya, Ravi; Ort, Tatiana; Wang, Weirong
Journal:
MAbs
Issue:
Volume 12:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A. Issue 1 (1st January 2020)

Authors:
Zheng, Songmao; Shen, Fang; Jones, Brian; Fink, Damien; Geist, Brian; Nnane, Ivo; Zhou, Zhao; Hall, Jeff; Malaviya, Ravi; Ort, Tatiana; Wang, Weirong
Journal:
MAbs
Issue:
Volume 12:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Issue 2 (28th January 2023)

Authors:
Nahi, Hareth; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Oriol, Albert; Plesner, Torben; Bandyopadhyay, Nibedita; Hellemans, Peter; Tromp, Brenda; Nnane, Ivo; Zemlickis, Donna; Chari, Ajai; Moreau, Philippe
Journal:
Leukemia & lymphoma
Issue:
Volume 64:Issue 2(2023)
Page Start:
468
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Daratumumab in transfusion‐dependent patients with low or intermediate‐1 risk myelodysplastic syndromes. Issue 4 (31st January 2021)

Authors:
Garcia‐Manero, Guillermo; Diez‐Campelo, Maria; Vellenga, Edo; Jacoby, Meagan A.; Merchan, Brayan; Breems, Dimitri; Cortelezzi, Agostino; Doronin, Vadim; Gomez, Valle; Beckers, Marielle; Della Porta, Matteo Giovanni; Varsos, Helen; Xiu, Liang; DeAngelis, Nikki; Nnane, Ivo; Rose, Esther; van Eygen,...
Journal:
American journal of hematology
Issue:
Volume 96:Issue 4(2021)
Page Start:
E111
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review. Issue 5 (9th January 2023)

Authors:
Xu, Zhenhua; Leu, Jocelyn H.; Xu, Yan; Nnane, Ivo; Liva, Sophia G.; Wang‐Lin, Shun Xin; Kudgus‐Lokken, Rachel; Vermeulen, An; Ouellet, Daniele
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 113:Issue 5(2023)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis. (28th November 2021)

Authors:
Luo, Man (Melody); Zhu, Peijuan (Penny); Nnane, Ivo; Xiong, Yuan; Merlini, Giampaolo; Comenzo, Raymond L; Kastritis, Efstathios; Wechalekar, Ashutosh D.; Weiss, Brendan M.; Tran, NamPhuong; Qin, Xiang; Vermeulen, Jessica; Sharma, Amarnath; Sun, Yu‐Nien; Zhou, Honghui
Journal:
Journal of clinical pharmacology
Issue:
Volume 62:Number 5(2022)
Page Start:
656
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Population pharmacokinetics and exposure–response analyses of daratumumab plus pomalidomide/dexamethasone in relapsed or refractory multiple myeloma. Issue 5 (28th December 2022)

Authors:
Dosne, Anne‐Gaelle; Li, Xia; Luo, Man Melody; Nnane, Ivo; Dimopoulos, Meletios A.; Terpos, Evangelos; Sonneveld, Pieter; Kampfenkel, Tobias; Carson, Robin; Amin, Himal; Perez Ruixo, Juan; Zhou, Honghui; Sun, Yu‐Nien; Xu, Yan
Journal:
British journal of clinical pharmacology
Issue:
Volume 89:Issue 5(2023)
Page Start:
1640
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis. Issue 12 (14th June 2020)

Authors:
Nnane, Ivo; Frederick, Bart; Yao, Zhenling; Raible, Donald; Shu, Cathye; Badorrek, Philipp; van den Boer, Maarten; Branigan, Patrick; Duffy, Karen; Baribaud, Frédéric; Fink, Damien; Yang, Tong‐Yuan; Xu, Zhenhua
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 12(2020)
Page Start:
2507
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗